Abstract:Quality assurance in laboratory medicine started in the Federal Republic of Germany in 1971 with the publication of the "Guidelines of the German Medical Association for the implementation of a statistical quality control and round robin tests in the field of medicine". Since then quality assurance in general has developed further and the "Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations" (abbreviated Rili-BAEK) has been refined in numerous revisions to date. In 2008, the foundation stone for the current structure of the Rili-BAEK was laid [1]: A: Basic requirements for quality assurance in medical laboratory examinations B: Special Parts B 1: Quantitative medical laboratory examinations B 2: Qualitative medical laboratory examinations B 3: Direct detection and characterisation of infectious agents B 4: Examinations of ejaculate B 5: Molecular genetic and cytogenetic medical laboratory examinations C: Advisory board D: Expert groups E: Reference institutions E 1: General requirements for reference institutions conducting external quality assurance programmes E 2: Special requirements for reference institutions F: Temporary regulations G: Entry into force The great importance of the Rili-BAEK is reflected in its explicit mention in Section 10 (1) of the Medical Devices Operator Ordinance (MPBetreibV) from 2024, which passed the resolution by the upper house of the German parliament on July 5th 2024 and states that [2]: "Anyone who carries out laboratory medical examinations must establish a quality assurance system in accordance with the state of the art in medical science and technology to maintain the necessary quality, safety and performance in the use of in vitro diagnostics and to ensure the reliability of the results obtained prior incepting this activity. Proper quality assurance in accordance with sentence 1 is assumed if the 'Guideline of the German Medical Association on Quality Assurance of Laboratory Medical Examinations' in the version of 30 May 2023 (Deutsches Ärzteblatt of 30 May 2023, DOI: 10.3238/arztebl.2023.rili_baek_Labor) is observed." When the Rili-BAEK was revised in 2019, Part A was modernised with regard to quality management. Contents of the general quality management standard of the Federal Joint Committee (G-BA) were incorporated (i.e. structure and process quality, continuous improvement, high level on patient safety, effort in reasonable proportion to the equipment) [3] and important elements from the DIN EN ISO 9001:2015 were adopted (i.e. documented information, documentation on the quality management instead of the quality management manual) [4]. The way was paved for using process-orientated quality management systems in the future and the concept of risk-based quality assurance was introduced. Furthermore, the peer review was anchored in the Rili-BAEK as an important element of medical quality assurance. The peer review contains a professional dialogue in multiprofessional cooperation on the same level not only involving doctors and scientists but also technicians. The German Medical Association provides a curriculum for this that can be employed for advanced training to become a peer. Reactions on the introduction of the peer reviews in laboratory medicine were positive throughout [5]. Within the revision of the Rili-BAEK 2019 the increased medical demands on measurement quality – on the example of HbA 1c – were incorporated [6]. Since HbA 1c according to the guidelines not only is a measurand for patient follow-up but can also be used for the diagnosis of diabetes mellitus medical demands on measurement quality have tightened. In this context the demands on the internal quality assurance decreased from ±10 % via ±5 % to ±3 % with a transition period of four years. This adaptation was necessary, because in the case of a deviation of measurement of ±4 % with a true HbA 1c value of 44 mol/mol Hb the results are both in the range of no risk for diabetes mellitus ( 47 mmol/mol Hb). Therefore, with the former demands on measurement quality it was impossible to guarantee a reliable diagnosis of diabetes mellitus. Later on in 2023 the American Association for Clinical Chemistry and the American Diabetes Association recommended in a joint publication an intralaboratory CV for HbA 1c of 1.5 % [7]. In the Rili-BAEK 2023 the demands on the external quality assurance (round robin tests) decreased from ±18 % to ±8 %. Furthermore, demands on the internal quality assurance for further 30 measurands were defined, quality criteria for the diagnostic in cerebrospinal fluid were revised and the specimen dried blood for Newborn Screening was added. In the Parts B 2 and B 3 the number of measurands with external quality assurance was increased by 10 and the risk-based qualit -Abstract Truncated-

[Organization of laboratories in the German Democratic Republic]

German Society for Clinical Chemistry and Laboratory Medicine – areas of expertise: Division reports from the German Congress of Laboratory Medicine 2022 in Mannheim, 13–14 October 2022

Editorial to the revision of the "Guideline of the German Medical Association on quality assurance in medical laboratory examinations – Rili-BAEK"

Benchmarking medical laboratory performance on a global scale

Harmonization in laboratory medicine: more than clinical chemistry?

Laborqualität sichern – molekular- und zytogenetische Ringversuche des BVDH e. V.

[Limitations to the physician's discretionary and therapeutic freedom and to the provision of health care for the general population by a shortage of financial and human resources--the rules of Section 2 Para. 1 and 4 of the Medical Professional Code of conduct and how much they are really worth]

Critical test result management at Danish hospital laboratories: a national survey

Occupational health care in small and medium sized enterprises--How many doctors do we need and how do we ensure good care?

Comment on: A systematic approach of correct laboratory commissioning – special procedural features for medical laboratories using the example of specialised forms of care: supplement and update to the articles in J Lab Med 2014; 38(4): 179–205 and J Lab Med 2015; 39(4): 213–239

Reference, calibration and referral laboratories – a look at current European provisions and beyond

[Routine Practice Data for Health Care Analyses: Part 3 of the Manual]

Laboratory Medicine is Faced with the Evolution of Medical Practice

[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024]

The status and future of clinical pathology in Korea

A systematic approach of correct laboratory commissioning: special procedural features for medical laboratories using the example of specialised forms of care

[Young Respiratory Physicians in Germany - Current Situation and Future Perspectives]

Die psychiatrische Rehabilitation in der DDR vor dem Hintergrund sowjetischer Einflüsse

A comparative analysis of the doctoral regulations at the medical faculties in Germany

[Changes in the provision of psychiatric services at a psychiatric district hospital]

Serological testing in a microbiology laboratory of specimens from patients with suspected infectious disease.